J. Ladoabeal et al., MENSTRUAL ABNORMALITIES IN WOMEN WITH CUSHINGS-DISEASE ARE CORRELATEDWITH HYPERCORTISOLEMIA RATHER THAN RAISED CIRCULATING ANDROGEN LEVELS, The Journal of clinical endocrinology and metabolism, 83(9), 1998, pp. 3083-3088
Menstrual irregularity is a common complaint at presentation in women
with Gushing's syndrome, although the etiology has been little studied
. We have assessed 45 female patients (median age, 32 yr; range, 16-41
yr) with newly diagnosed pituitary-dependent Cushing's syndrome. Pati
ents were subdivided into 4 groups according to the duration of their
menstrual cycle: normal cycles (NC; 26-30 days), oligomenorrhea (OL; 3
1-120 days), amenorrhea (AM; >120 days), and polymenorrhea (PM; <26 da
ys). Blood was taken at 0900 h for measurement of LH, FSH, PRL, testos
terone, androstenedione, dehydroepiandrosterone sulfate, estradiol (E-
2), sex hormone-binding globulin (SHBG), and ACTH; cortisol was sample
d at 0900, 1800, and 2400 h. The LH and FSH responses to 100 mu g GnRH
were analyzed in 23 patients. Statistical analysis was performed usin
g the nonparametric Mann-Whitney U and Spearman tests. Only 9 patients
had NC (20%), 14 had OL (31.1%), 15 had AM (33.3%), and 4 had PM (8.8
%), whereas 3 had Variable cycles (6.7%). By group, AM patients had lo
wer serum E-2 levels (median, 110 pmol/L) than OL patients (225 pmol/L
; P < 0.05) or NC patients (279 pmol/L; P < 0.05), and higher serum co
rtisol, levels at 0900 h (800 vs. 602 and 580 nmol/L, respectively; P
< 0.05) and 1800 h (816 vs. 557 and 523 nnol/L, respectively; P < 0.05
) and higher mean values from 6 samples obtained through the day (753
us. 491 and 459 nmol/L, respectively; P < 0.05). For the whole group o
f patients there was a negative correlation between serum E-2 and cort
isol at 0900 h (r = -0.50; P < 0.01) and 1800 h (r = -0.56; P < 0.01)
and with mean cortisol (r = -0.46; P < 0.05). No significant correlati
on was found between any serum androgen and E-2 or cortisol. The LH re
sponse to GnRH was normal in 43.5% of the patients, exaggerated in 52.
1%, and decreased in 4.4%, but there were no significant differences a
mong the menstrual groups. No differences were found in any other para
meter. In summary, in our study 80% of patients with Gushing's syndrom
e had menstrual irregularity, and this was most closely related to ser
um cortisol rather than to circulating androgens. Patients with AM had
higher levels of cortisol and lower levels of E-2, while the GnRH res
ponse was either normal or exaggerated. Our data suggest that the mens
trual irregularity in Gushing's disease appears to be the result of hy
percortisolemic inhibition of gonadotropin release acting at a hypotha
lamic level, rather than raised circulating androgen levels.